Combining anti-PD-1 antibodies with surufatinib for gastrointestinal neuroendocrine carcinoma: Two cases report and review of literature

Figure 3 The treatment history of arterial embolism in patient 2 and the treatment plan for these two patients. A: ICI-TKI continuous treatment, left adrenal gland and hepatic metastasis chemoembolization, and X cycles of ICI-TKI rechallenge; B: Timeline of the diagnosis and treatment process for case 1; C: Timeline of the diagnosis and treatment process for case 2.